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Abstract
Background: To respond to the rapid surge in the incidence of suicide in Japan, which appears to
be an ongoing trend, the Japanese Multimodal Intervention Trials for Suicide Prevention (J-MISP)
have launched a multimodal community-based suicide prevention program, NOCOMIT-J. The
primary aim of this study is to examine whether NOCOMIT-J is effective in reducing suicidal
behavior in the community.
Methods/DesignThis study is a community intervention trial involving seven intervention regions
with accompanying control regions, all with populations of statistically sufficient size. The program
focuses on building social support networks in the public health system for suicide prevention and
mental health promotion, intending to reinforce human relationships in the community. The
intervention program components includes a primary prevention measures of awareness campaign
for the public and key personnel, secondary prevention measures for screening of, and assisting,
high-risk individuals, after-care for individuals bereaved by suicide, and other measures. The
intervention started in July 2006, and will continue for 3.5 years. Participants are Japanese and
foreign residents living in the intervention and control regions (a total of population of 2,120,000
individuals).
Discussion: The present study is designed to evaluate the effectiveness of the community-based
suicide prevention program in the seven participating areas.
Trial registration: UMIN Clinical Trials Registry (UMIN-CTR) UMIN000000460.
Background
Recent rapid increase of suicide in Japan
(1) Changes in suicide incidence
According to vital statistics collected by the Japan Ministry
of Health, Labour, and Welfare in 1997, there were 23,494
suicides (15,901 men and 7,593 women), with the
number rising to 31,755 (22,349 men and 9,406 women)
in 1998, which represented a 35% increase. This was the
highest rate of increase recorded since the Ministry began
tracking mortality statistics. The number of suicides
remained high in subsequent years, reaching 29,949 in
2002 and 32,109 in 2003.
In 2002, the World Health Organization (WHO) reported
that the suicide rate in Japan (25.3 per 100,000) was
higher than in any other developed nation (for compari-
son: France: 17.5, Germany: 13.5, Canada: 11.7, United
States of America: 10.4, United Kingdom: 7.5, Italy: 7.1).
In terms of the number of suicides, three peaks have
emerged since World War II. However, the most recent
rise that started in 1998 has shown no signs of abating,
and represents the worst in Japan's history. Therefore, it is
clear that suicide prevention measures are urgently
needed in Japan.
(2) Regional tendencies
It has been pointed out that the suicide rate has tradition-
ally been high in the three prefectures of the northern
Tohoku area (Akita, Iwate, and Aomori), Niigata, Shi-
mane, and the Kyushu area (Miyazaki, Kagoshima, and
Okinawa) [1].
The increase in the number of suicides that began in 1998,
however, was not necessarily attributable to suicides in
these rural areas. Fujita (2003) [2] conducted a compara-
tive study of suicide rates by prefecture by comparing a
time period with a low number of suicides (1989–1995)
to time periods before and after, during which the number
of suicides was on the rise (1983–1987 and 1998–2000,
respectively). The findings indicated that the recent
increase in the number of suicides has been significantly
more prominent in urban areas such as Tokyo, Osaka, and
their surrounding areas, than in rural areas. During the
two periods 1989–1995 and 1998–2000, the mean
number of suicides among people 15 years of age or older
rose from 894 to 1,658 in Osaka, from 713 to 1,309 in
Kanagawa, and from 1,129 to 1,938 in Tokyo.
With regard to recent trends in suicide rate by age, the
middle-aged population was found to have higher suicide
rates. In 2004, 42.1% of those who committed suicide
were 45 to 64 years old. This tendency was particularly
evident among men, in whom the suicide rate peaked at
55 to 59 years of age, whereas a similar trend was not
found in women, in whom the suicide rate generally
increased with age.
(3) Causes and motives for suicide
According to the statistics of the National Police Agency,
health and financial/lifestyle problems were the top two
reasons for suicide. Although this tendency remained the
same during the increase in suicides that began in 1998,
the number of suicides due to financial/lifestyle problems
has increased more rapidly compared to suicides commit-BMC Public Health 2008, 8:315 http://www.biomedcentral.com/1471-2458/8/315
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ted due to health problems. Among those who committed
suicide with or without suicide notes in 1997, 13,659
individuals (56.0%) did so due to health problems and
3,556 individuals (14.6%) due to financial/lifestyle prob-
lems. These numbers rose to 16,769 (51.0%, a 22.8%
increase over the previous year) and 6,058 (18.4%, a
70.4% increase over the previous year), respectively, in
1998. In terms of those with health problems, the number
of suicides subsequently decreased in 2004 to 14,786
(45.7%), whereas the number of suicides due to financial/
lifestyle problems increased to 7,947 (24.6%). This indi-
cates that the percentage of suicides due to financial/life-
style problems has been increasing.
Recent suicide prevention programs in Japan
Many suicide prevention measures have been imple-
mented internationally [3-5]. In Japan, evidence has also
emerged recently to support the effectiveness of commu-
nity-based programs for suicide prevention. Seven com-
munity-based intervention trials implemented for five
years or more have been conducted between 1985 and
2005 in Japan. All the trials used a quasi-experimental
design and included suicide rate as the primary outcome.
These suicide prevention programs included the develop-
ment of social support networks in the community and/
or depression screening for residents with follow-up by
physicians. All the intervention programs were also
administered by local governments. Six of the seven trials
targeted individuals aged 65 years and older.
The first trial was conducted in Matsunoyama, Niigata
prefecture. During the 10-year implementation period,
the suicide rate of over 150 per 100,000 decreased by 75%
for both men and women aged 65 years and older [6]. In
the trials conducted in Joboji (Iwate pref.), Nagawa
(Aomori pref.), Matsudai and Yasuzuka (Niigata pref.),
and Yuri (Akita pref.), the suicide prevention program sig-
nificantly reduced the suicide risk for individuals aged 65
years and older [7-10].
Recently, a relatively large, multimodal intervention trial
targeting all age groups was conducted in four municipal-
ities of Akita. During the four-year implementation
period, the suicide rate of 68 per 100,000 for all residents
was reduced by 27% [11].
The results of these seven trials suggest that community-
based intervention would be effective for preventing sui-
cide and that the increase of suicide deaths in Japan may
be related to more pervasive social isolation than in the
past, and to an absence of personal psycho-social develop-
ment compared with financial success.
However, the sample sizes in these trials were relatively
small and the monitoring of the implementation process
was insufficient. Furthermore, since the trials were con-
ducted in rural areas with high suicide rates, it is still
unclear whether similar community-based programs
would be effective in urban areas where the suicide rates
have increased rapidly. Therefore large, community-based
intervention trials with adequate controls should be con-
ducted to develop an effective, evidence-based suicide pre-
vention program to reduce the future suicide rate in Japan.
Objectives of this study
(1) The primary goal is to examine the effectiveness of a
community-based multimodal intervention program for
suicide prevention in regions where the suicide rate was
relatively high compared to control regions. These target
areas were designated "Group 1".
(2) The secondary goal was to explore the effectiveness of
a community-based multimodal intervention program for
suicide prevention in highly populated regions. These tar-
get areas were designated "Group 2".
Methods/Design
A community intervention trial will be conducted to eval-
uate the effectiveness of a novel suicide intervention pro-
gram. In this study, the incidence of suicidal behavior in
an intervention group and a control group will be com-
pared.
Organization
The Japan Ministry of Health, Labour, and Welfare
selected the Japan Foundation for Neuroscience and Men-
tal Health (JFNMH) as the primary institution responsible
for the strategic research program for suicide prevention.
The JFNMH conducts the program "Japanese Multimodal
Intervention Trials for Suicide Prevention, J-MISP" in
close collaboration with the National Center of Neurol-
ogy and Psychiatry. NOCOMIT-J is one of two research
projects being conducted by J-MISP. The other is a rand-
omized, controlled, multicenter trial of post-suicide
attempt case management for prevention of further
attempts in Japan (ACTION-J).
The principal investigator of NOCOMIT-J and the sub-
leader will supervise the study group in order to conduct
and complete the study effectively.
The study group management office will engage in overall
administrative procedures regarding the operation of the
study group. It will also set up and operate the study group
steering committee and the intervention program com-
mittees, hold the research conference, and respond to
questions from institutions in the participating regions.
The J-MISP director, the principal investigator of the
NOCOMIT-J, and the regional leaders share the informa-BMC Public Health 2008, 8:315 http://www.biomedcentral.com/1471-2458/8/315
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tion and collaborate to resolve problems and safety issues
with the help of the steering committee and the Central
and Local Research Ethics Committee.
The study group steering committee will be composed of
regional leaders and other key members of the study
group. Research meetings will be held upon the principal
investigator's request. At the meetings, the intervention
program committee will present the agenda, after which
important issues, such as revision of the protocol or stop-
ping of the study, will be discussed.
Participants and Participating Areas
Participants
The participants will include Japanese and foreign resi-
dents living in the intervention and control regions.
Eligibility Criteria
Target areas will be selected and divided into two groups:
"Group 1" and "Group 2" as mentioned above. The areas
meeting the following criteria will be eligible for the
study:
a) Areas with strong support from local government and
other organizations to conduct this multimodal suicide
prevention program.
b) Areas capable of selecting intervention and control
regions.
c) Areas capable of following the data collection proce-
dure.
d) Areas with comparable baseline data on suicide
attempts in intervention and control regions.
e) Areas with comparable baseline demographic data in
intervention and control regions.
Participating regions and sample size estimation
(1) Group 1: Regions in Aomori, Akita, Iwate, and the
Minamikyushu area, with a total population of 670,000
individuals.
(2) Group 2: Regions in Sendai, Chiba, and the Kitaky-
ushu area, with a total population of 1,450,000 individu-
als.
After a preliminary survey to record the rate of suicidal
behavior and other information in the target regions in
these areas, intervention and control regions will be
selected based on the similarity in community character-
istics and the incidence of suicidal behavior (Figure 1).
Each region has a designated regional leader. The person-
nel associated with each region include psychiatrists,
researchers supporting community intervention, and per-
sonnel in charge of regional health administration.
Rationale for estimation of sample sizes
Sample sizes to be used in the study were calculated based
on the assumptions of the outcome and suicide rates from
2002 to 2004 in Groups 1 and 2 presented in Table 1.
Although the estimated sample sizes are not adjusted for
5-year age group, sex, and regional characteristics, if all
assumptions are met, the statistical power will be over
80% for each group, regarding person-year incidences in
the intervention and control regions.
Using the O'Brien-Fleming method [12] in the interim
analysis, the significance level in the final analysis is esti-
mated to be 4.9% for a two-sided test. In addition, the sta-
tistical power will be over 80% in each group.
Intervention
The intervention program will be implemented by local
authorities.
Suicide prevention program in control regions
The interventions in the control regions include the usual
suicide prevention programs.
Suicide prevention programs in intervention regions
The local health authorities will implement the suicide
prevention measures in accordance with the intervention
manual developed by the program committee of the study
group. To better enhance the quality of the essential inter-
vention activities, the local health authority is also
requested to share with the other study group members
the information on the program tools.
Flow diagram of the study Figure 1










programs as usual 
Participating Areas BMC Public Health 2008, 8:315 http://www.biomedcentral.com/1471-2458/8/315
Page 5 of 8
(page number not for citation purposes)
The program components
The program stresses that bonds between human beings,
social support, and social capital within communities are
key factors for reducing suicide. Its essential components
are listed below.
(1) The program focuses on building social support net-
works in the public health system for suicide prevention
and mental health promotion, which will reinforce
human relationships in the community.
- Network meetings of related departments and organiza-
tions will be held.
- Coordinating committees for the program will be
formed in the intervention regions.
(2) Primary prevention measures for suicide and suicide-
related behavior
- An public awareness campaign will be set up.
- Community programs will be set up to allow residents to
gather and communicate.
(3) Secondary prevention measures for suicide and sui-
cide-related behavior
- High-risk individuals will be screened.
- Counseling and outreach services will be provided.
(4) After-care for individuals bereaved by suicide
(5) Suicide prevention measures targeting individuals
with substance/alcohol-related disorders, schizophrenia,
and other mental health disorders
(6) Suicide prevention measures targeting individuals
with work-related problems.
Study period
Study period: August 2005 to March 2010.
Intervention period: July 2006 to December 2009.
Approval of the study protocol
This study protocol was reviewed and approved by the
Central Research Ethics Committee of the J-MISP. Addi-
tionally, the regional leaders will ask the local governors
for cooperation, and obtain written authorization to con-
duct the study. Regional leaders will obtain approval from




Data will be collected for the items below:
(1) Statistics on suicide
The number of suicides in the 3 years prior to the study
(2003–2005) in the study regions was recorded by sex and
5-year age group the Japan Ministry of Health, Labour,
and Welfare.
(2) Information from the emergency report
Information on "self-harmed" individuals transported by
ambulance in the 3 years prior to the study was collected
from the emergency reports of ambulance service.
(3) Demographic information
A total population count in the regions in the 3 years prior
to the study was recorded by sex and 5-year age group by
each local governments.
(4) Regional characteristics
The following information was collected from published
statistical data sources: geographic information, propor-
tion of unmarried individuals, widowed spouses, divor-
cees, nuclear families, the unemployed, individuals in the
labor force, and the annual population turnover in the
regions.
Table 1: Assumptions of the outcome and suicide rates in Group 1 and Group 2
Group 1 Group 2
Suicide rate in control regions (per 100,000 individuals) 30 20
Proportion of expected numbers of ambulance transports due to "self-harm" (severe and mild cases) relative to completed 
suicides
50% 50%
Expected suicide rate reduction over observed 3 years by intervention 20% 15%
Significance level (two-sided) 5% 5%
Notes. These assumptions of the outcome and suicide rates (2002–2004) are used to calculate the sample sizes in this study.
Group1: regions with a relatively high suicide rate compared to control regions, examined to gauge the effectiveness of the community-based 
multimodal intervention program for suicide prevention.
Group 2: highly-populated regions, examined in order to explore the effectiveness of the community-based multimodal intervention program for 
suicide prevention.BMC Public Health 2008, 8:315 http://www.biomedcentral.com/1471-2458/8/315
Page 6 of 8
(page number not for citation purposes)
(5) Suicide prevention programs in existence prior to the study
Baseline information concerning suicide prevention pro-
grams implemented in each region 3 years prior to the
study will be recorded by each regions.
Intervention program process monitoring
Every 6 months, each regional leader will collect informa-
tion regarding the implemented projects described in the
intervention program manual.
Data collection during the study
(1) Information on suicides
After consent is obtained for the use of designated statis-
tics for other purposes, information regarding the number
of suicides in the participating regions will be collected.
Death certificates from the Vital Statistics records from
2006, 2007, 2008, and 2009 for the intervention and con-
trol regions will be used to collect the following data
items: International Classification of Diseases 10th Revi-
sion (ICD-10) code for intentional self-harm (ICD-10
codes X60–X84), residence of individuals who committed
suicide (municipality codes), cause of death, external
cause of death (ICD-10 code), measure of suicide (ICD-
10), sex, age, reported place (municipality codes), and
identification number.
(2) Information regarding suicidal behavior
Information regarding "self-harmed" individuals trans-
ported by ambulance will be collected from emergency
reports.
The following information will be collected regarding
"self-harmed" individuals every 6 months: type of trans-
portation, date of notification, residence address, destina-
tion address, incidence location, severity (death, severe,
moderate, mild, other), sex, age, and means of self-harm
infliction.
(3) Demographic information
Total population numbers in the regions will be collected
every year between 2006 and 2009.
(4) Information regarding ongoing suicide prevention programs
Information regarding the existence and implementation
of suicide prevention programs in each participating
region will be collected every 6 months.
Responsibility for data collection
Regional leaders are responsible for collecting data from
each municipality and sending the data set to the data
management center in a timely manner.
Data management
Collected data will be exclusively managed by the data
management center. The data set will comply with the
data management procedures and the Personal Informa-
tion Protection Law. The data set will be periodically
duplicated and saved as a backup file.
Outcomes
Primary outcome
The incidence of suicidal behavior (completed suicides
and suicide attempts excluding mild cases reported on
emergency reports).
Secondary outcomes
(1) Incidence of completed suicides.
(2) Incidence of suicide attempts.
Statistical analysis
Primary analysis
In the primary analysis, the incidence of suicidal behavior
will be calculated based on the number of suicidal behav-
ior per person-year for the annual population. Data
obtained will include the incidence of suicidal behavior
and its 95% confidence intervals adjusted by sex, 5-year
age group, and regional characteristics. This data will be
compared between the intervention and control regions
in "Group 1".
The significance level will be set at 0.05 for the two-sided
test, and will be adjusted in the final analysis based on the
methods of O'Brien and Fleming [12] for interim analysis.
Additionally, regression analysis will also be performed to
examine the interactions among sex, 5-year age group,
and regional characteristics. A statistician in the study
group will determine the analysis plan, whereas a differ-
ent independent statistician will perform the interim anal-
ysis. The independent statistician will not contribute to
the revision of the statistical analysis plan after interim
analysis.
Interim analysis and rules for stopping or revising the study protocol
The interim analysis in "Group 1" will be performed 2
years after the study's implementation to evaluate the
achievement of the primary objectives. Multiplicity will be
adjusted using the methods of O'Brien and Fleming, in
order to maintain Type-1 error at 0.05 for the two-sided
test. The results will be reported to the Central Research
Ethics Committee, which is expected to make recommen-
dations to the J-MISP director to either stop the study or
revise the study protocol if the primary objective of the
study has already been achieved or is unlikely to be
achieved.
Secondary analysis
In addition to the primary analysis, it will also be evalu-
ated whether the primary outcome (the incidence of sui-BMC Public Health 2008, 8:315 http://www.biomedcentral.com/1471-2458/8/315
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cidal behavior) is also significantly reduced in
intervention regions of "Group 2" areas, as a consequence
of implementation of the program, when compared to
control regions. The incidence of suicidal behavior will be
investigated in Groups 1 and 2 combined. The analysis
will be performed using the primary analysis plan
described above.
Secondary outcomes will also be examined in order to
determine whether the rate of completed suicides and sui-
cide attempts – including individuals with severe, moder-
ate, and mild self-harm transported to a hospital – is
significantly reduced in the intervention regions, when
compared to the control regions in "Group 1" and "Group
2". The same will be examined for both groups combined.
Subgroup analysis of the primary and secondary out-
comes will be performed by sex, 5-year age group, and
regional characteristics in "Group 1", "Group 2", and both
groups combined. In addition, the incidence of suicidal
behavior adjusted by sex and 5-year age group in the inter-
vention and control regions will be calculated using the
model population in 1985 as a reference population.
Because of the exploratory nature of the secondary analy-
sis, no adjustment for multiplicity will be made.
Ethical considerations
The rights and welfare of the participating residents will
be protected according to the World Medical Association
Declaration of Helsinki Ethical Principles for Medical
Research Involving Human Subjects. The study will com-
ply with the ethical guidelines of the Ministry of Educa-
tion, Culture, Sports, Science and Technology, as well as
the Ministry of Health, Labour, and Welfare. Ethical valid-
ity, including safety, scientific legitimacy, and the reliabil-
ity of results are to be ensured. This study will also comply
with the ethical guidelines for epidemiologic studies and
the Personal Information Protection law. The NOCOMIT-
J principal investigator and the J-MISP director will be
responsible for the protection of personal information
during the study.
The data collected in this study will not include personal
identification that would enable individuals to be identi-
fied. The data management center will collect only anon-
ymous data.
Stopping of the study
The J-MISP director is to inform the principal investigator
of the NOCOMIT-J of the decisions of the Central
Research Ethics Committee in the cases described below
to discuss whether the study in each region or all of them
should be discontinued.
a) The results of the interim analysis do not satisfy the
standards set by the committee.
b) Safety issues that might affect the conduct of future
studies arise from the results of interim analysis or the
results of periodic monitoring.
c) The Local Research Ethics Committee of a region
retracts consent to participate.
Revision of the study protocol and due process
The J-MISP director is to inform the NOCOMIT-J princi-
pal investigator of the decisions of the Central Research
Ethics Committee as soon as possible, when the Central
Research Ethics Committee recommends that the study be
redesigned due to the emergence of safety issues based on
the interim analysis, periodic monitoring, and/or emer-
gence of serious issues that might affect the conduct of
future studies. The J-MISP director is to call a meeting of
the study group and discuss the revision of the study pro-
tocol. If a recommendation to revise the study protocol is
made, the principal investigator of the NOCOMIT-J will
propose the revised study protocol as soon as possible and
submit the proposal to the J-MISP director.
The J-MISP director will deliberate and approve the pro-
posal at the Central Research Ethics Committee meeting
and adopt the revision of the study protocol after deliber-
ation in the steering committee. The study group manage-
ment office will inform all of the participating researchers,
and regional leaders will submit the proposed revision to
the Local Research Ethics Committee and local govern-
ment in each of the participating regions. The revision of
the study protocol is to be implemented when approved.
Study monitoring
Periodic monitoring
The regional leaders will periodically (once every 6
months) submit reports evaluating the progress of the
study to the intervention program committee. The inter-
vention program committee will submit a process evalua-
tion monitoring report to the study group management
office and J-MISP administration office once every 6
months. The J-MISP administration office will consider
the progress of the research and submit the process evalu-
ation monitoring report to the progress control commit-
tee and the Central Research Ethics Committee of the J-
MISP.
The data management center will submit an event moni-
toring report to the J-MISP administration office. The
office will submit event monitoring reports to the progress
control committee, Central Research Ethics Committee,
and the study group management office. The event moni-
toring report, which will contain the results of the analysisPublish with BioMed Central    and   every 
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separated by intervention and control groups, will be sub-
mitted to the progress control committee and Central
Research Ethics Committee. The results of the data ana-
lyzed from both groups combined will be submitted to
the study group management office.
The progress control committee will examine the moni-
toring reports and submit the evaluation to the J-MISP
director. The Central Research Ethics Committee will
examine the monitoring reports as a third party, and make
recommendations to revise the study protocol or discon-
tinue the study to the J-MISP director when and if ethical
problems, such as safety and efficacy issues, arise.
Monitoring reports
The process evaluation monitoring report will contain the
following:
(1) An evaluation of the implementation progress of the
study.
(2) A program process evaluation.
(3) Reports of individual cases and events requiring inter-
vention and other information.
The event monitoring report will contain the following:
(1) Data on the incidence of suicidal behavior (total
number of both suicide completions and attempts) in the
intervention and control groups, etc.
(2) Other relevant information.
Discussion
The study presented here is designed to evaluate the effec-
tiveness of the community-based suicide prevention pro-
gram in seven participating areas. Because treatment and
prevention of suicide are complex and encompass many
factors, success
will need multi-sector collaboration. We hope that the
results of NOCOMIT-J will help to develop effective strat-
egies to reduce future suicide rate in Japan.
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